Johnson & Johnson vs Vericel Corporation: SG&A Expense Trends

SG&A Expense Trends: A Tale of Two Companies

In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a critical measure of a company's operational efficiency. Over the past decade, Johnson & Johnson and Vericel Corporation have showcased contrasting trends in their SG&A expenses.

Johnson & Johnson: Stability Amidst Change

From 2014 to 2023, Johnson & Johnson's SG&A expenses have remained relatively stable, averaging around $21 billion annually. Despite a slight dip in 2022, the company rebounded in 2023, reflecting its robust financial management and adaptability in a dynamic market.

Vericel Corporation: A Growth Story

In contrast, Vericel Corporation has experienced a remarkable increase in SG&A expenses, growing nearly tenfold from 2014 to 2023. This surge underscores Vericel's aggressive expansion strategy and investment in growth initiatives.

These trends highlight the diverse strategies employed by companies in managing operational costs, offering valuable insights for investors and analysts alike.